Oral Cancer News

Males can get HPV vaccine Gardasil thanks, in part, to Gulfport cancer survivor

Source: St. Petersburg Times Author: John Barry David Hastings’ crusade to inoculate boys against a cancer-causing virus that afflicts women — but threatened him, too — has scored a victory. But it’s not quite the one he has been fighting for in the past three years. A panel of the Centers for Disease Control and [...]

Continue reading...

HPV vaccine fails to get nod for routine use in boys

Source: Medscape.com Author: Robert Lowes October 21, 2009 — Despite hearing impassioned pleas to protect both men and women from cancer, a federal advisory panel today declined to recommend that a human papillomavirus (HPV) vaccine be routinely administered to boys to prevent genital warts. Instead, the Advisory Committee on Immunization Practices (ACIP) issued a “permissive” [...]

Continue reading...

37% of U.S. teen girls got HPV vaccine

Source: www.medscape.com Author: Daniel J. DeNoon More than one in three U.S. teen girls has had at least one shot of Gardasil, a CDC survey shows, but only 18% of girls got the three shots needed for protection. The survey includes girls vaccinated through 2008, two years after Gardasil’s approval. A second HPV vaccine, GlaxoSmithKline’s [...]

Continue reading...

Initial COIN study results presented at European Oncology Congress

Source: Drugs.com Author: Staff • Results inconsistent with data from all Erbitux pivotal studies • Further analyses planned by the Medical Research Council that conducted the independent COIN study Berlin/Darmstadt, Germany, September 23, 2009 – The Medical Research Council (MRC), a UK-based, publicly-funded organization dedicated to improving human health, today presented the initial results of [...]

Continue reading...

Drugmaker Merck seeks Gardasil approval for boys

Source: www.forbes.com Author: Linda A. Johnson Drugmaker Merck & Co. has asked federal regulators to approve use in males for its vaccine against the human papillomavirus, which causes cervical and other sexually transmitted cancers. The application was submitted in late December, Merck spokeswoman Amy Rose said Tuesday. It was long planned as part of Whitehouse [...]

Continue reading...